Adamed aims for Finnish hearts
Last week the company announced that their cardiac drug Amlozek was registered in Finland. Amlozek has been available in Poland since 1998 and is now in the top 10 best-selling drugs in Poland. Some 450,000 patients use it every month.
Finland is the sixth market in the European Union where Adamed will sell its products. The company is also exporting to Spain, Portugal, Czech Republic, Slovakia and Hungary. In Finland, the drug will be distributed by a local partner.
Finland is the sixth market in the European Union where Adamed will sell its products. The company is also exporting to Spain, Portugal, Czech Republic, Slovakia and Hungary. In Finland, the drug will be distributed by a local partner.
